Jacques Otten
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Neurology top 5%
- Neuroblastoma Research and Treatments 7
- CNS Lymphoma Diagnosis and Treatment 3
-
- Acute Lymphoblastic Leukemia research 19
- Genetics top 10%
- Glioma Diagnosis and Treatment 4
-
- Childhood Cancer Survivors' Quality of Life 11
- Pharmaceutical studies and practices 3
-
- Histiocytic Disorders and Treatments 2
In The Last Decade
Jacques Otten
35 papers receiving 946 citations
Peers
Comparison fields: 5 of 72
- Hematology 297
- Neurology 263
- Public Health, Environmental and Occupational Health 456
- Pathology and Forensic Medicine 260
- Genetics 142
Countries citing papers authored by Jacques Otten
This map shows the geographic impact of Jacques Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Otten more than expected).
Fields of papers citing papers by Jacques Otten
This network shows the impact of papers produced by Jacques Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Otten. The network helps show where Jacques Otten may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques Otten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 39 | |
| 2 | 2010 | 40 | |
| 3 | 2006 | 1 | |
| 4 | 2005 | 9 | |
| 5 | 2002 | 9 | |
| 6 | 2002 | 9 | |
| 7 | 2001 | 21 | |
| 8 | 2001 | 7 | |
| 9 | 1998 | 113 | |
| 10 | 1996 | 19 | |
| 11 | 1994 | 53 | |
| 12 | 1993 | 1 | |
| 13 | 1992 | 11 | |
| 14 | 1991 | 214 | |
| 15 | 1990 | 25 | |
| 16 | 1990 | 29 | |
| 17 | Rapid High-Dose Intensity Chemotherapy Including High-Dose Melphalan (Hdm) for Rhabdomyosarcoma | 1988 | 1 |
| 18 | 1987 | 5 | |
| 19 | [Xanthoma, neurofibromatosis and leukemia in children]. | 1984 | 2 |
| 20 | 1983 | 16 |
About Jacques Otten
Jacques Otten is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 35 papers that have together received 989 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (19 papers), Childhood Cancer Survivors' Quality of Life (11 papers), Acute Myeloid Leukemia Research (8 papers), Neuroblastoma Research and Treatments (7 papers), Glioma Diagnosis and Treatment (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Pharmaceutical studies and practices (3 papers) and Histiocytic Disorders and Treatments (2 papers). The work is most often cited by research in Hematology (297 citations), Neurology (263 citations) and Public Health, Environmental and Occupational Health (456 citations). Jacques Otten has collaborated with scholars based in Belgium, France and Portugal. Frequent co-authors include J.C. Gentet, Thierry Philip, Stefan Suciu, C Rodary, F Pein, D Dufillot, J M Zucker, Catherine Patte, H. Behrendt and Yves Benoît. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Pediatric Hematology/Oncology, European Journal of Cancer and Archives of Disease in Childhood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.